Adalvo Ltd., G.L. Pharma GmbH, Saneca Pharmaceuticals a.s., S.C. Labormed-Pharma S.A.
PolandAll drugs from this manufacturer
-
The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery. It is also used to treat deep vein thrombosis in the legs and pulmonary embolism, as well as to prevent the recurrence of clots.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg ATC: B01AF01
-
In adults, it is used to prevent strokes and blood clots (in atrial fibrillation), as well as to treat and prevent deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat clots in the veins or lungs following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg ATC: B01AF01
-
In adults, it is used to prevent strokes in people with atrial fibrillation and in the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg ATC: B01AF01